ALNOV.PA
Novacyt SA
Price:  
0.47 
EUR
Volume:  
130,436.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA EV/EBITDA

-570.4%
Upside

As of 2025-09-16, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -0.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 14.73 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -15.58 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.8x - 12.3x 8.7x
Forward P/E multiples 11.3x - 15.9x 13.8x
Fair Price (2.22) - (2.45) (2.22)
Upside -570.9% - -619.6% -570.4%
0.47 EUR
Stock Price
(2.22) EUR
Fair Price

ALNOV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-12 -0.90
2025-09-11 -0.96
2025-09-10 -0.98
2025-09-09 -0.83
2025-09-08 -0.84
2025-09-05 -0.86
2025-09-04 -0.88
2025-09-03 -0.85
2025-09-02 -0.86
2025-09-01 -0.91
2025-08-29 -0.96
2025-08-28 -0.96
2025-08-27 -0.96
2025-08-26 -0.92
2025-08-25 -1.00
2025-08-22 -0.95
2025-08-21 -0.98
2025-08-20 -0.93
2025-08-19 -0.96
2025-08-18 -1.01
2025-08-15 -0.95
2025-08-14 -1.03
2025-08-13 -1.17
2025-08-12 -0.83
2025-08-11 -0.81
2025-08-08 -0.82
2025-08-07 -0.84
2025-08-06 -0.84
2025-08-05 -0.85
2025-08-04 -0.82
2025-08-01 -0.87
2025-07-31 -0.89
2025-07-30 -0.93
2025-07-29 -0.93
2025-07-28 -0.92
2025-07-25 -0.97
2025-07-24 -1.00
2025-07-23 -0.94
2025-07-22 -0.91
2025-07-21 -0.94
2025-07-18 -0.93
2025-07-17 -0.95
2025-07-16 -0.95
2025-07-15 -0.94
2025-07-14 -0.96
2025-07-11 -0.95
2025-07-10 -0.96
2025-07-09 -0.95
2025-07-08 -0.94
2025-07-07 -0.98